(3E,5E,7R,8R,9S,11E,13E,15S,16R)-16-[(2S,3R,4S)-4-[(2S,4S,5R,6S)-2,4-dimethoxy-5-methyl-6-propan-2-yloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one
C37H62O9 — CID 164620625
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3E,5E,7R,8R,9S,11E,13E,15S,16R)-16-[(2S,3R,4S)-4-[(2S,4S,5R,6S)-2,4-dimethoxy-5-methyl-6-propan-2-yloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one
(3E,5E,7R,8R,9S,11E,13E,15S,16R)-16-[(2S,3R,4S)-4-[(2S,4S,5R,6S)-2,4-dimethoxy-5-methyl-6-propan-2-yloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one (PubChem CID 164620625) has the molecular formula C37H62O9 and a molecular weight of 650.89 g/mol. Its IUPAC name is (3E,5E,7R,8R,9S,11E,13E,15S,16R)-16-[(2S,3R,4S)-4-[(2S,4S,5R,6S)-2,4-dimethoxy-5-methyl-6-propan-2-yloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one.
Molecular Properties
| Compound Name | (3E,5E,7R,8R,9S,11E,13E,15S,16R)-16-[(2S,3R,4S)-4-[(2S,4S,5R,6S)-2,4-dimethoxy-5-methyl-6-propan-2-yloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one |
|---|---|
| PubChem CID | 164620625 |
| Molecular Formula | C37H62O9 |
| Molecular Weight | 650.89 g/mol |
| Exact Mass | 650.44 |
| IUPAC Name | (3E,5E,7R,8R,9S,11E,13E,15S,16R)-16-[(2S,3R,4S)-4-[(2S,4S,5R,6S)-2,4-dimethoxy-5-methyl-6-propan-2-yloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one |
| SMILES | CO/C1=C/C(C)=C/[C@@H](C)[C@H](O)[C@@H](C)C/C(C)=C/C=C/[C@H](OC)[C@@H]([C@@H](C)[C@@H](O)[C@H](C)[C@]2(OC)C[C@H](OC)[C@@H](C)[C@H](C(C)C)O2)OC1=O |
| InChI | InChI=1S/C37H62O9/c1-21(2)34-26(7)31(43-12)20-37(44-13,46-34)28(9)33(39)27(8)35-29(41-10)16-14-15-22(3)17-24(5)32(38)25(6)18-23(4)19-30(42-11)36(40)45-35/h14-16,18-19,21,24-29,31-35,38-39H,17,20H2,1-13H3/b16-14+,22-15+,23-18+,30-19+/t24-,25+,26+,27-,28-,29-,31-,32+,33+,34-,35+,37-/m0/s1 |
| InChIKey | GBIVMOGRTDNWIQ-WJSDPXCFSA-N |
| XLogP | 6.00 |
| TPSA | 112.91 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 650.89 |
| LogP ≤ 5 | 6.00 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164620625 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.